Logo
    Search

    #197 - The science of obesity & how to improve nutritional epidemiology | David Allison, Ph.D.

    enFebruary 28, 2022

    Podcast Summary

    • Challenges and pitfalls in obesity research and public health measuresRenowned expert Allison emphasizes the importance of scientific rigor, integrity, and clear communication in obesity research, acknowledging potential confounding of science and advocacy, and suggesting that perceived lack of credibility may not be a failure of the scientific method but rather a communication issue.

      Allison, a renowned expert in obesity and nutrition with over 500 scientific publications and numerous awards, discussed the challenges and pitfalls in the field of obesity research and public health measures. He emphasized the need for scientific rigor and integrity, as well as the potential confounding of science and advocacy. Allison also offered insights into the current state of science and its perceived lack of credibility, suggesting that the issue may not be with the scientific method itself but rather with the way it is communicated and perceived in the context of advocacy. Overall, this conversation provides valuable insights into the complexities of obesity research and the importance of maintaining a clear and logical perspective in the pursuit of knowledge.

    • Exploring obesity with intellectual curiosityRenowned obesity researcher, Dr. Barzilai, approaches his field with a scientific, evidence-based perspective, emphasizing the importance of treating obesity research like any other scientific discipline

      Dr. Barzilai, a renowned obesity researcher, approaches his field with intellectual curiosity and a lack of emotion, despite the loaded nature of the topic. His background in psychology and statistical analysis has shaped his evidence-based perspective, leading him to question assumptions and seek solid data. He became interested in obesity research during his graduate studies, driven by a desire to understand the complexities of the condition using scientific methods. Dr. Barzilai emphasizes the importance of treating obesity research like any other scientific field, applying the same laws of probability, physics, and mathematics to better understand the underlying causes and potential solutions.

    • From individual causes to environmental factors in obesity researchObesity research has evolved from focusing on individual causes to recognizing the impact of environmental factors, particularly a toxic food environment, on obesity rates.

      The study of obesity and its causes has evolved significantly over the years. The speaker, who was introduced to the subject in the late 80s during her undergraduate studies at Vassar College, was fascinated by the work of psychologist Stanley Schachter and his external theory of obesity. At the time, obesity was not a major public health concern, and the medical and political views towards it were different. However, as the 90s approached, obesity rates began to rise dramatically, leading to a shift in perspective. The focus moved from individual causes to environmental factors, with the recognition that a toxic food environment plays a significant role in obesity. This shift was driven in part by data from the National Health Nutrition Examination Survey (NHANES) and the work of researchers like Kelly Brownell, who advocated for a more preventative approach to childhood obesity. Overall, the study of obesity has shown that there is no one-size-fits-all solution, and that a multi-faceted approach is necessary to understand and address this complex issue.

    • The Causes of Obesity: A Complex IssueThe causes of obesity are complex and likely involve a combination of genetic, environmental, and behavioral factors, requiring rigorous research for accurate understanding.

      The obesity epidemic was initially viewed as an environmental, social, and political problem, which led to increased funding and attention. However, this shift also brought less rigorous research and more opinion and advocacy. Before the 1990s and the introduction of large-scale studies like NHANES 3, the belief about the cause of obesity was unclear and often attributed to behavioral factors such as overeating. However, the thinking was sloppy, and it's important to note that behavior is inherently linked to biology. While there is evidence of a genetic component, such as selective breeding of animals, the exact causes of obesity are complex and likely involve a combination of genetic, environmental, and behavioral factors.

    • Genetic component of obesity in identical twinsIdentical twins' BMI shows strong genetic correlation, with evidence dating back to 1923, but effective and sustainable treatments for obesity remain elusive.

      The correlation between identical twins' Body Mass Index (BMI) is nearly the same, whether they were reared together or separated at birth. This high degree of concordance suggests a significant genetic component to obesity. However, it took several decades for this understanding to emerge in the scientific community. Early hints of the genetic component were present in studies as early as 1923, but it wasn't until the 1980s, with the high-quality twin and adoption studies from Sweden and Denmark, that the genetic component became clear. Despite this knowledge, the focus on obesity treatment remained on behavioral interventions such as counseling, reducing energy intake, and developing tools to help people do so. It wasn't until the early 1990s that pharmaceutical interventions began to be explored, with the introduction of fenfluramine and phentermine (Fenfen), which unfortunately had dangerous side effects for a small subset of people. Overall, the scientific understanding of the genetic component of obesity has evolved significantly over the past century, but effective and sustainable treatments continue to be a challenge.

    • The Fenfen era: A turning point in obesity treatment historyThe Fenfen era, marked by the use of fenfloramine and fentermine for obesity, boosted credibility of pharmaceutical interventions, despite later withdrawal due to valvulopathy, and paved way for more effective treatments.

      The history of obesity treatments, specifically Fenfen (a combination of fenfloramine and fentermine), marks a turning point in the credibility of pharmaceutical interventions for obesity. Originally used for depression, fenfloramine was later combined with fentermine due to observed weight loss benefits. While some unscrupulous providers misused it, others used it responsibly. The drug showed promising results, leading to increased attention and research into potential obesity treatments. However, the fenfloramine component was later found to cause a valvulopathy, leading to its withdrawal. Despite this setback, the Fenfen era sparked a shift in perception towards obesity as a serious medical disorder, paving the way for more credible and effective treatments. The mechanism of Fenfen's effects was not fully understood, but it was believed to involve both serotonergic and adrenergic components. The Swedish obese subject study later played a significant role in increasing the credibility of surgical approaches to obesity treatment. Overall, the history of Fenfen demonstrates the complex and evolving nature of obesity treatments, with both successes and setbacks, and the ongoing quest for effective and safe interventions.

    • Study Challenged Belief That Surgery for Weight Loss Didn't Extend LifeWeight loss surgery leads to significant reductions in mortality and obesity, with benefits particularly noticeable for individuals with type 2 diabetes, reducing mortality risk by 50-60% on average.

      A study conducted by Lars Seostrum in the 1980s challenged the belief that surgery for weight loss did not extend life, despite it being a common belief at the time. Seostrum, inspired by his mentor Pierre Bjornthorp's work on fat cell theories, conducted a controlled trial where he compared the outcomes of obese individuals who underwent surgery with closely matched controls receiving usual care. The study, published in the New England Journal of Medicine over a decade later, showed that surgery led to significant reductions in mortality and obesity. Since then, numerous studies, some randomized, have confirmed the positive effects of weight loss surgery on longevity and overall health. The risk reduction in mortality varies from study to study, typically ranging between 50% and 60%. The benefits are particularly noticeable among individuals with type 2 diabetes. However, the effects on conditions like hypertension are less sustained. The obesity paradox, which refers to the U-shaped relationship between body weight and mortality, has been observed for decades, with individuals at both extremes of the BMI spectrum experiencing increased mortality rates. The causes of this paradox are still being researched.

    • The relationship between BMI and mortality changes with ageOlder adults may have a lower risk of dying from major illnesses or injuries if they are heavier, a phenomenon known as the obesity paradox. The optimal BMI for lowest mortality may shift to the right as people age, potentially towards heavier values.

      The relationship between body mass index (BMI) and mortality is not straightforward, and it may change as people age. Older adults, who are more likely to have major illnesses or injuries, may have a lower risk of dying from these conditions if they are heavier. This phenomenon, known as the obesity paradox, is still a subject of ongoing research and debate. The data do not definitively prove any one hypothesis, and there are multiple competing explanations. For example, one model suggests that obesity may increase the likelihood of getting a major illness or injury in the first place, but once someone has one, being heavier may reduce the risk of dying from it. The optimal BMI for lowest mortality may shift to the right as people age, meaning it could be heavier than for younger adults. However, this is a rough estimate, and there are many other factors, such as race and sex, that need to be considered. The exact movement of the nadir of the U-shaped curve by decade is not precisely known, but it is thought to move towards heavier BMI values as people age. For instance, the nader might be near 20 when someone is in their 20s, but it could be well above 30 when they are in their 80s.

    • BMI and mortality: Complex relationship influenced by confounding factorsAnalyzing BMI and mortality requires a nuanced perspective, considering multiple studies and factors like body composition and smoking to account for confounding.

      The relationship between Body Mass Index (BMI) and mortality is complex and can be influenced by confounding factors. For instance, individuals with low BMIs may have higher mortality rates due to chronic diseases that lead to muscle wasting. However, excluding early deaths from the analysis does not reliably help reduce confounding. Instead, researchers must triangulate the answer from multiple studies and consider other factors like body composition and confounders such as smoking. The challenge lies in the observational nature of the research, which makes it difficult to establish causality and control for all potential confounders. Ultimately, it's crucial to approach the analysis with a critical and nuanced perspective, recognizing the limitations and potential biases in the data.

    • The complex relationship between obesity and mortalityWhile BMI can indicate potential health risks, it's important to remember that it's just one measure and should not be used alone for clinical diagnoses. Changing societal norms and reduced stigma associated with higher BMIs may impact the BMI associated with the lowest mortality.

      The relationship between obesity and mortality is complex and not fully understood. Early research suggested a U-shaped curve, but confounding factors such as cigarette smoking, socioeconomic status, and stigma may have influenced the results. The BMI associated with the lowest mortality has been increasing over time, possibly due to changing societal norms and reduced stigma associated with higher BMIs. The key question is the effect of interventions, such as surgery, GLP1 agonists, and SGLT2 inhibitors, on longevity. BMI, while a useful tool for epidemiologic research, has limitations, particularly in assessing body composition. It was developed based on the assumption that mass increases proportionally to the cube of a linear dimension, but this is not the case for humans. The BMI of an NBA center, for example, may be greater than 30, but this does not necessarily indicate unhealthiness. It's important to remember that BMI is just one measure and should not be used in isolation for clinical diagnoses.

    • BMI and health outcomes vary across ethnicities and populationsUnderstanding the complex relationship between BMI, ethnicity, socioeconomic status, and health outcomes is crucial for accurate health assessments and effective public health interventions.

      The relationship between Body Mass Index (BMI) and health outcomes, such as obesity and mortality, varies across different ethnicities and populations. While the general concept of a concave up curve exists, the shape and position of the curve can differ significantly among different age, race, and sex groups. For instance, individuals of Middle Eastern and East Asian descent may experience increased health risks at lower BMIs compared to other populations. Additionally, socioeconomic status and ethnicity can influence obesity levels differently for various demographics. For example, among African American women, there is a significant gender and ethnicity difference in obesity rates, whereas among Hispanic Americans, both men and women have higher obesity levels than European Americans, but no association between BMI and mortality has been found. It's essential to recognize the complexity and nuances of obesity and its relationship to various factors, including ethnicity, socioeconomic status, and individual health outcomes.

    • BMI may not be the most accurate tool for assessing health and body fatMore sophisticated methods like 3D photography and density measurement may provide more accurate results, but simpler tools like BMI are sufficient for some purposes, and the ultimate goal is to use these tools to improve health outcomes.

      While Body Mass Index (BMI) is a commonly used metric for measuring obesity and health, it may not be the most accurate or effective tool, especially when considering individual health and metabolic factors. The speaker suggests that more sophisticated methods, such as 3D photography and density measurement, may provide more accurate results for assessing body fat and health. However, these methods may not be necessary for population-level data or for simple comparisons. The ultimate goal should be to use these tools to improve health outcomes, rather than just gathering data for comparison purposes. The speaker emphasizes the importance of considering the "so what" question – what can be done with the information obtained – and the need for more research and development in this area.

    • Community initiatives may not significantly impact obesity levelsIndividualized treatments like surgery, pharmaceuticals, and therapy may be more effective in reducing obesity and improving health

      Addressing obesity through community initiatives, such as farmers markets or vending machine changes, may not have a significant impact on obesity levels. Instead, focusing on individualized treatments like bariatric surgery, pharmaceuticals, and cognitive behavioral therapy may be more effective in reducing obesity and improving health. The evolutionary explanation for why weight loss is difficult to maintain is also complex and not definitively answered. The "thrifty gene hypothesis" suggesting humans evolved to preserve energy is simplistic and not supported by all evidence. Other theories, such as freedom from predation, may provide alternative explanations.

    • The complexities of evolution: Appetite, weight, and sexual reproductionEvolution is a complex process influenced by various factors, and understanding it requires considering multiple theories. For example, the shift from prey to predators influenced genes regulating appetite and weight, while sexual reproduction may have been driven by multiple hypotheses to ensure survival against rapidly evolving microbes.

      The evolution of organisms, including humans, is a complex process influenced by various factors, some of which may not have a straightforward explanation. For instance, the shift from being prey to predators led to the selection of genes that regulate appetite and weight, but it wasn't about making us fatter. Instead, it was a consequence of the genes no longer being selected for keeping us thin. Similarly, the evolution of sexual reproduction, despite being less efficient from a genetic perspective, may have been driven by various hypotheses working together to ensure survival in the face of rapidly evolving microbes. These examples illustrate that evolution is a complex and multifaceted process, and understanding it requires considering multiple factors and theories.

    • The complex relationship between food intake and evolutionSome suggest thrifty genes influence food intake during scarcity, while others propose food safety may impact consumption. Nutritional epidemiology offers insights but faces criticism for inconsistent findings.

      The relationship between food intake and evolution, as well as the role and limitations of nutritional epidemiology, are complex issues with various perspectives. Some researchers suggest that the thrifty gene theory, which posits that individuals may evolve a desire to eat more when food is scarce to increase reproductive fitness, could be a factor. Others propose that the safety of food, meaning the potential exposure to microbes and toxins, may influence food intake. Regarding nutritional epidemiology, some argue that it is a valuable tool for gaining insights into nutrition and public health, while others believe it has reached its peak of utility and should focus on other problems. The debate continues, with critics pointing out that many findings from nutrition epidemiology have not held up in randomized controlled trials. Ultimately, both fields offer valuable perspectives, but it is important to recognize their limitations and continue to explore new avenues of research.

    • Challenges in observational nutrition studiesObservational studies in nutrition face significant challenges including confounding and measurement errors, making it difficult to establish causation. Rigorous study design and analysis are crucial to overcome these issues and establish causation.

      While observational studies in nutrition epidemiology can provide valuable associations, they often face significant challenges such as confounding and measurement errors that make it difficult to establish causation. These issues are particularly prevalent in nutrition studies due to the complexities involved in measuring food intake and other lifestyle factors. The speaker argues that the status quo is unacceptable and calls for reform in the field, while also acknowledging the importance of using these tools effectively. A notable example given is a mouse study where researchers randomly assigned mice to different calorie intakes, finding that the observational component showed an opposite association to the causal effect in the experimental component. This highlights the need for caution when interpreting observational studies and the importance of rigorous study design and analysis to establish causation.

    • Exploring alternative study designs in nutritional epidemiologyAlternative study designs, such as those using co-twins or interventions, can provide valuable insights despite not being randomly assigned. However, there are concerns regarding food intake measurement and the use of hazard ratios, emphasizing the need for transparency and constructive debates.

      While randomized controlled trials are considered the gold standard in research, there is a need to explore other study designs, such as those using co-twins or interventions, even if not randomly assigned. These designs can provide valuable insights and are stronger than simple observational studies. However, there are concerns regarding the accuracy of measuring food intake in nutritional epidemiology, and the use of hazard ratios to make grand statements about causal relationships can be misleading. It's crucial to acknowledge the limitations of our knowledge and approach research with honesty and humility, engaging in constructive debates focused on the data rather than personal attacks. The field of nutritional epidemiology would benefit from a greater level of transparency and recognition of the challenges in measuring food intake, even in well-designed studies.

    • The reliability of self-reported methods for measuring energy intake and expenditureDespite limitations, self-reported methods can provide valuable data for certain research questions. Media sensationalism and ad hominem attacks can overshadow scientific findings, but focusing on data, methods, and logic is crucial for productive scientific discourse.

      The reliability of self-reported methods for measuring energy intake and expenditure is a subject of debate in scientific research. While these methods may not be perfect, they can still provide valuable information for certain research questions, such as dietary patterns or food frequency. However, their use should be carefully considered and justified based on the specific research goals. Another important takeaway is the impact of media and public perception on scientific research, particularly in the field of nutrition and obesity. The example of Catherine Flegel's 2005 paper on BMI and mortality rate shows how media sensationalism and ad hominem attacks can overshadow the actual scientific findings and hinder productive scientific discourse. Ultimately, it is crucial to focus on the data, methods, and logic in scientific research, rather than getting sidetracked by personal attacks or public opinion. Despite the challenges, it is essential to continue engaging in rigorous scientific inquiry to advance our understanding of complex issues like obesity and nutrition.

    • One-size-fits-all diet solutions don't work for weight lossProgress on effective nutritional treatments for weight loss is limited, individual experiences and circumstances matter, and a multi-faceted approach is necessary.

      When it comes to nutrition and weight loss, there is no one-size-fits-all solution. People have strong feelings about food and making decisions about what to eat, often justifying them based on their experiences rather than data. While we have made significant progress in surgical and pharmacologic treatments for obesity, progress on the nutritional front is not clear. The idea that there is a good diet for sustained weight loss for most people is a misperception. It's important to consider that for some individuals, maintaining a healthy weight may not be achievable through diet alone. Instead, we should focus on a multi-faceted approach that includes research funding for effective treatments, making these treatments more accessible to those who need them, and recognizing that individual experiences and circumstances play a significant role in weight management.

    • Focusing on reducing stigma and increasing access to healthcare instead of shaming individualsInstead of shaming individuals for body habits, prioritize reducing stigma and increasing access to healthcare. Improve the quality of research in obesity and nutrition with evidence-based solutions.

      Shaming individuals based on their body habits, whether it's weight gain or loss, is not an acceptable or productive approach. Instead, we should focus on reducing stigma and increasing access to healthcare. The scientific community needs to improve the quality of research in the field of obesity and nutrition, and tackle the issue with the same rigor as other scientific fields. Cluster randomized trials, which assign entire groups to conditions instead of individuals, can lead to distorted evidence if not properly analyzed for clustering and nesting effects. We need to prioritize real science and evidence-based solutions to address obesity and nutrition issues, rather than continuing to look for answers under the lampposts. Ultimately, it's important to remember that shaming people based on their body habits, or any other characteristic, is not a moral or acceptable solution. We should strive for progress and understanding, rather than perpetuating harmful stereotypes and practices.

    • Recognizing clusters and improving education for better public healthUnderstanding complex societal structures and addressing education and socioeconomic disparities can lead to improved public health outcomes.

      The complexity of human behavior and societal structures necessitates a more nuanced approach to understanding and addressing public health issues. Dr. Finkelstein emphasized the importance of recognizing clusters or groups within populations, rather than treating each individual as an isolated case. He also highlighted the significance of education, particularly general education for girls and women, as a potential intervention for reducing obesity and related health issues. The research suggests that education can lead to better health outcomes, and policies that increase access to education may have long-term benefits. Additionally, reducing socioeconomic disparities could also be an effective strategy for improving public health. The National Academy of Sciences, Engineering and Medicine panel on reproducibility in science concluded that while there isn't a crisis, there should be no complacency, and efforts should be made to improve the rigor and honesty of scientific research.

    • Recognizing the need for improvements in scienceWhile science has made great strides, it's important to address issues of trust, integrity, and rigor through ongoing efforts to improve the scientific enterprise

      While there may not be an existential crisis in science, there is a growing recognition that improvements are necessary. The speakers in the discussion agree that science is in a better state than it has ever been, but there are valid concerns about trust, integrity, and rigor. They highlight examples of both normative and non-normative errors in scientific history, acknowledging that mistakes are a natural part of the scientific process. However, they also emphasize the importance of addressing non-normative errors, such as those influenced by societal biases and inequalities. The ongoing efforts of organizations like the National Academy of Sciences and the National Science Foundation to address these issues underscore the commitment to continually improving the scientific enterprise.

    • Prevalence of non-normative errors in nutrition epidemiologyTransparency, professional statisticians, and critical questioning are essential to minimize non-normative errors in nutrition epidemiology, ensuring accurate and harmless interventions.

      The field of nutrition epidemiology has seen numerous non-normative errors, which include misinterpretation of data from undernourished children, misanalysis of cluster randomized trials, and the use of food frequency questionnaires to draw causal inferences. These errors can lead to significant issues, such as promoting interventions that may cause harm. It's crucial for scientists to be transparent, use professional statisticians, and avoid using rhetorical devices that can undermine the credibility of scientific findings. Additionally, society as a whole needs to elevate the level of dialogue on epistemological and empirical issues, making it a norm to ask critical questions about scientific claims and demand robust evidence. The loss of public trust in science, particularly evident during the COVID-19 pandemic, underscores the importance of this approach. By consistently adhering to these principles, we can strengthen the scientific community's ability to communicate complex ideas effectively and maintain public trust.

    • Distinguishing Roles of Scientists as SpeakersScientists must distinguish between speaking truthfully as experts and advocating for a cause, while addressing the challenge of building trust in science through clear communication.

      During the COVID-19 pandemic, the importance of truth and clear communication in science has come under scrutiny. David Allison, a professor of biostatistics and epidemiology, emphasizes the need for scientists to distinguish between speaking as scientists, where truth must never be compromised, and speaking as advocates, where persuasion is the goal. He also highlights the challenge of trust in science, not because people don't trust it as a process, but because they struggle to distinguish between trustworthy and untrustworthy sources. Allison believes that this issue is particularly evident in nutrition science, where trust in dietitians, medical doctors, and even nutrition scientists varies widely. The key is for scientists to be clear about their roles and to communicate truthfully when speaking as scientists.

    • Understanding the difference between science and advocacy in nutritionNutrition scientists and advocates have distinct roles, and transparency about which hat is being worn can improve communication and trust.

      The distinction between science and advocacy is crucial, especially in the field of nutrition. According to David L. Katz, MD, there's a significant gap between the credibility of nutrition scientists and that of dietitians and medical doctors in the public's perception. He believes this is due to the obfuscation, exaggeration, and hype that have tarnished the reputation of nutrition science. Katz suggests a "two hat system" where individuals can wear both scientist and advocacy hats but must clearly indicate which one they're wearing. As a father, he uses the analogy of giving advice to his kids, acknowledging that sometimes he speaks as a concerned parent without needing to provide scientific evidence. Overall, the importance of understanding the difference between science and advocacy, and being transparent about which role one is playing, can lead to more effective communication and trust-building.

    Recent Episodes from The Peter Attia Drive

    #307 ‒ Exercise for aging people: where to begin, and how to minimize risk while maximizing potential | Peter Attia, M.D.

    #307 ‒ Exercise for aging people: where to begin, and how to minimize risk while maximizing potential | Peter Attia, M.D.

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    In this special episode, Peter addresses the common questions about starting or returning to an exercise routine over the age of 50. Individuals in this age group have frequently reached out with questions about whether it's too late to start exercising and often express concern over a lack of prior training, a fear of injury, or uncertainty about where to begin. Peter delves into the importance of fitness for older adults, examining all four pillars of exercise, and provides practical advice on how to start exercising safely, minimize injury risk, and maximize potential benefits. Although this conversation focuses on people in the “older” age category, it also applies to anyone of any age who is deconditioned and looking to ease into regular exercise.

    We discuss:

    • Key points about starting exercise as an older adult [2:45];
    • Why it’s never too late to begin exercising and incorporating the four pillars of exercise [5:45];
    • The gradual, then sharp, decline in muscle mass and activity level that occur with age [10:00];
    • The decline of VO2 max that occurs with age [15:30];
    • Starting a training program: exercise variability, movement quality, realistic goals, and more [18:30];
    • Improving aerobic capacity: the malleability of the system, the importance of consistency, and setting long-term fitness goals [25:15];
    • Starting cardio training: base building, starting with low volume, and zone 2 training [30:45];
    • The critical role of VO2 max in longevity [36:45];
    • How to introduce VO2 max training to older or deconditioned individuals [46:15];
    • Options for performing zone 2 and VO2 max training [53:45];
    • The ability to make gains in strength and muscle mass as we age [57:00];
    • How to implement strength training for older individuals [1:01:00];
    • Advice for avoiding injury when strength training [1:07:30];
    • Risk of falls: the devastating consequences and the factors that increase fall risk [1:12:15];
    • Mitigating fall risk: the importance of foot and lower leg strength, ankle mobility, and balance [1:19:45];
    • Improving bone mineral density through resistance training [1:24:30];
    • The importance of protein in stimulating muscle protein synthesis, especially in older adults [1:31:00];
    • Parting advice from Peter [1:34:00]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    The Peter Attia Drive
    enJune 24, 2024

    #306 - AMA #60: preventing cognitive decline, nutrition myths, lowering blood glucose, apoB, and blood pressure, and more

    #306 - AMA #60: preventing cognitive decline, nutrition myths, lowering blood glucose, apoB, and blood pressure, and more

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    In this “Ask Me Anything” (AMA) episode, Peter provides insights on a broad range of important topics. He delves into the prevention of cognitive decline, the link between cardiovascular disease and Alzheimer's disease, and methods to lower blood glucose, insulin, and apoB. He also addresses nutrition-related queries, exploring the impact of dietary habits on weight loss and longevity, how a person can identify the best diet for themselves, and common nutrition myths. Additional discussions include optimal blood pressure, daily step goals, the benefits of standing versus sitting desks, and much more.

    If you’re not a subscriber and are listening on a podcast player, you’ll only be able to hear a preview of the AMA. If you’re a subscriber, you can now listen to this full episode on your private RSS feed or our website at the AMA #60 show notes page. If you are not a subscriber, you can learn more about the subscriber benefits here.

    We discuss:

    • Overview of topics and episode format [1:40];
    • Preventing cognitive decline [5:00];
    • How to lower blood glucose and insulin [13:30];
    • The relationship between lipids, CVD, and Alzheimer’s disease, and whether statins can increase the risk of neurodegenerative disorders and AD [23:15];
    • Reducing apoB levels through exercise and diet [31:45];
    • Pharmacological options for lowering apoB [38:00];
    • How nutrition impacts longevity via metabolic health, muscle mass, BMD and more [40:15];
    • How can someone determine the best diet for themselves? [43:45];
    • Nutrition myth: All weight loss is good [46:45];
    • Nutrition myth: Metabolic rates are dramatically different among individuals based on genetics [49:00];
    • Nutrition myth: Losing weight after a brief period of overeating is impossible [53:45];
    • Nutrition myth: GLP-1 agonists are a replacement for a healthy lifestyle [57:45];
    • Nutrition myth: There is a single best diet for weight loss [1:03:00];
    • Nutrition oversimplification: All calories are created equal [1:05:45];
    • Daily step goals [1:06:45];
    • The benefits of standing versus sitting throughout the day [1:10:45];
    • How to identify the most impactful and easiest-to-implement ways to improve your health [1:12:30];
    • The critical importance of emotional health [1:14:30];
    • Why supplements should be considered as supportive aids rather than primary solutions in one’s strategy to improve longevity [1:18:00];
    • Strategies for reducing high blood pressure [1:20:45];
    • Peter’s biggest frustrations with "mainstream health advice" [1:28:00];
    • Peter’s chaotic, yet cherished, morning routine [1:31:00]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    The Peter Attia Drive
    enJune 17, 2024

    #305 ‒ Heart rate variability: how to measure, interpret, and utilize HRV for training and health optimization | Joel Jamieson

    #305 ‒ Heart rate variability: how to measure, interpret, and utilize HRV for training and health optimization | Joel Jamieson

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    Joel Jamieson is a conditioning expert who developed Morpheus to give people a smarter way to build their conditioning regimen and improve their recovery. In this episode, Joel dives deep into the world of heart rate variability (HRV), explaining its scientific foundation, how it measures the balance between the sympathetic and parasympathetic nervous systems, the various methods of measurement, and how it can guide healthier lifestyle choices and improved training performance. He explores the nuances of HRV calculation, the impact of aging on HRV, and the roles of genetics, exercise, and other lifestyle factors in this process. He also covers Morpheus, the innovative training tool that won Peter over after his initial skepticism, highlighting its practicality and effectiveness in guiding training and optimizing fitness outcomes.

    We discuss:

    • Heart rate variability (HRV): evolution, science, and practical applications of HRV in athletic training [4:00];
    • Methods of measuring HRV: EKG, wrist-based sensors, and more [11:30];
    • How HRV is calculated from the data [22:30];
    • The role of the autonomic nervous system (ANS) in regulating HRV [25:45];
    • The decline in HRV with age, and the mitigating effects of fitness and other lifestyle factors [33:30];
    • The role of genetics in HRV, the modifiability of HRV, and a comparison of VO2 max and HRV as predictors of mortality [37:00];
    • How aging affects HRV and sympathetic drive, and the importance of spontaneous movement and exercise in maintaining the body's adaptability [43:30];
    • How Morpheus measures HRV using RMSSD and normalizes it to a 100-point scale for easier interpretation [49:45];
    • The Morpheus system: development, integration with various metrics, and personalized daily training recommendations to optimize fitness and recovery [51:30];
    • The benefits of morning HRV readings for assessing daily readiness compared to overnight HRV measurements [1:03:00];
    • Why Morpheus recommends using a chest strap rather than an arm band [1:10:00];
    • The impact of consistent exercise, stress, alcohol, and other lifestyle factors on HRV [1:11:15];
    • Optimizing zone 2 training with Morpheus [1:18:15];
    • Using heart rate recovery (HRR) as an indicator of athletic conditioning and the balance between aerobic and anaerobic systems [1:22:45];
    • The importance of tracking HRV trends over time rather than focusing on data from a given day [1:29:00];
    • Effect of GLP-1 agonists on heart rate and HRV [1:34:45];
    • Where HRV belongs in the hierarchy of health metrics [1:42:00];
    • Parting thoughts [1:46:30]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    The Peter Attia Drive
    enJune 10, 2024

    #304 – NEW: Introducing quarterly podcast summaries - Peter shares his biggest takeaways on muscle protein synthesis, VO2 max, toe strength, gut health, and more

    #304 – NEW: Introducing quarterly podcast summaries - Peter shares his biggest takeaways on muscle protein synthesis, VO2 max, toe strength, gut health, and more

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    In this quarterly podcast summary (QPS) episode, Peter introduces a new format aimed at summarizing his biggest takeaways from the last three months of guest interviews on the podcast. Peter shares key insights from each episode, covering diverse topics such as protein and muscle building with Luc van Loon, toe strength with Courtney Conley, VO2 max with Olav Aleksander Bu, liquid biopsies for cancer with Alex Aravanis, gut health and probiotics with Colleen Cutcliffe, and road safety with Mark Rosekind. Additionally, Peter shares any personal behavioral adjustments or modifications to his patient care practices that have arisen from these engaging discussions.

    If you’re not a subscriber and are listening on a podcast player, you’ll only be able to hear a preview of the AMA. If you’re a subscriber, you can now listen to this full episode on your private RSS feed or our website at the episode #304 show notes page. If you are not a subscriber, you can learn more about the subscriber benefits here.

    We discuss:

    • How Peter keeps track of his takeaways from each podcast episode [5:15];
    • Luc van Loon episode: fat utilization, muscle protein synthesis, dietary protein, aging and inactivity, and more [8:45];
    • Behavioral changes that have come about from the conversation with Luc van Loon [23:45];
    • Courtney Conley episode: importance of toe strength and the impact of dedicated foot training [26:45];
    • Olav Aleksander Bu episode: the importance of VO2 max for lifespan, and the practicalities of measuring and improving VO2 max [36:45];
    • Behavioral changes that have come about from the conversation with Olav [56:00];
    • Alex Aravanis episode: liquid biopsies for cancer detection [1:01:30];
    • Colleen Cutcliffe episode: the importance of gut bacteria balance, and the potential therapeutic uses of probiotics, particularly Akkermansia [1:16:45];
    • Mark Rosekind: the significant issue of road fatalities and injuries, their causes, and practical safety measures to reduce risks [1:27:00]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    The Peter Attia Drive
    enJune 03, 2024

    #303 - A breakthrough in Alzheimer’s disease: the promising potential of klotho for brain health, cognitive decline, and as a therapeutic tool for Alzheimer's disease | Dena Dubal, M.D., Ph.D.

    #303 - A breakthrough in Alzheimer’s disease: the promising potential of klotho for brain health, cognitive decline, and as a therapeutic tool for Alzheimer's disease | Dena Dubal, M.D., Ph.D.

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    Dena Dubal is a physician-scientist and professor of neurology at UCSF whose work focuses on mechanisms of longevity and brain resilience. In this episode, Dena delves into the intricacies of the longevity factor klotho: its formation and distribution in the body, the factors such as stress and exercise that impact its levels, and its profound impact on cognitive function and overall brain health. Dena shares insights from exciting research in animal models showing the potential of klotho in treating neurodegenerative diseases as well as its broader implications for organ health and disease prevention. She concludes with an optimistic outlook for future research in humans and the potential of klotho for the prevention and treatment of Alzheimer’s disease.

    Disclosure: Peter is an investor in Jocasta Neuroscience, a company working to develop klotho as a therapy for people with Alzheimer’s disease.

    We discuss:

    • Dena’s fascination with aging and how she came to study klotho [3:30];
    • Biological properties of klotho: production, regulation, decline with age, and factors influencing its levels [11:45];
    • Potential benefits of klotho on brain health [22:00];
    • The relationship between soluble klotho protein, platelet factors, and cognitive enhancement [33:45];
    • The role of platelet factor 4 (PF4) and it’s interaction with GluN2B in mediating cognitive enhancement [46:45];
    • Benefits of klotho observed in a mouse model of Parkinson’s disease [55:45];
    • Benefits of klotho observed in a mouse model of Alzheimer’s disease [1:03:00];
    • Promising results of klotho in primate models, and the importance of finding an appropriate therapeutic dose before moving to human trials [1:08:00];
    • Speculating why a single klotho injection has such long-lasting effects [1:25:30];
    • Potential cognitive benefits of klotho in humans, the impact of the KL-VS genetic variant on klotho levels, and the need for human trials to confirm these effects [1:27:45];
    • The interaction between the KL-VS genetic variant and APOE4 and how it impacts risk of Alzheimer’s disease [1:34:45];
    • The significance of klotho levels: studies linking lower levels to increased mortality and the broader implications for organ health and disease prevention [1:47:15];
    • Measuring klotho levels and determining an individual’s KL-VS status [1:52:15];
    • The promising potential of klotho for Alzheimer’s disease treatment, and the importance of philanthropy for funding research [1:58:00]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    The Peter Attia Drive
    enMay 27, 2024

    #302 - Confronting a metabolic epidemic: understanding liver health and how to prevent, diagnose, and manage liver disease | Julia Wattacheril, M.D., M.P.H.

    #302 - Confronting a metabolic epidemic: understanding liver health and how to prevent, diagnose, and manage liver disease | Julia Wattacheril, M.D., M.P.H.

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    Julia Wattacheril is a physician scientist and director of the Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) program at Columbia University Irving Medical Center. In this episode, Julia delves deep into the complex world of liver health, beginning with a foundational overview of liver physiology. She provides an in-depth look at how alcohol impacts liver function, breaking down the metabolism of ethanol and its detrimental effects. Julia then shifts the focus to understanding liver function tests and optimal enzyme levels, providing a detailed explanation of AST and ALT and elucidating why fluctuations in these levels may or may not be concerning. She provides a primer on the four major stages of liver disease, discussing risk and emphasizing the importance of early diagnosis. Julia highlights the role of liver disease in increasing the risk of cancer and cardiovascular disease and covers in detail the various strategies for diagnosing, treating, and preventing the progression of liver disease.

    We discuss:

    • Julia’s training, the importance of liver health, and the challenges and innovations of hepatology [3:15];
    • The complex and crucial functionality of the liver, its four most essential functions, and more [8:45];
    • Liver injuries: historical and evolving understanding of causal factors, and the progression to liver diseases and cancer [13:15];
    • How the liver metabolizes nutrients and what happens in the presence of excess calories or alcohol [24:45];
    • Methods of diagnosing liver disease and how insights guide treatment and management strategies [33:30];
    • The poisonous nature of ethanol to the liver [40:30];
    • Varied responses to alcohol, damaging effects of alcohol beyond the liver, and the process of advising patients on their alcohol consumption [47:15];
    • Understanding liver enzymes AST and ALT—interpreting levels, lifestyle factors that affect them, and diagnostic approaches [58:30];
    • Interpreting liver function tests for fatty liver disease, and the challenges of diagnosing liver pathologies, particularly in children versus adults [1:13:15];
    • Comprehensive liver health assessments via imaging and various diagnostic tools to prevent overlooking potential liver pathologies [1:18:45];
    • Potential impact of recreational drugs, statins, and other medications on liver function test results [1:26:45];
    • Shifting nomenclature from NAFLD to MASLD to reflect accuracy in the underlying pathophysiology and understanding of liver diseases [1:30:30];
    • Pathophysiology of MASLD, the need for proactive screening, and the significance of liver fat percentage as an indicator of metabolic health [1:36:30];
    • The importance of screening for rare conditions alongside common metabolic diseases associated with fatty liver accumulation [1:42:45];
    • Practical strategies for managing MAFLD [1:45:30];
    • The impact of fructose consumption on liver health and the challenges of disentangling its effects from other factors like obesity and insulin resistance [1:52:45];
    • The potential of GLP-1 agonists for the treatment of MASLD [1:57:45];
    • How the four stages of liver disease have evolved [2:00:30];
    • Increased cancer and heart disease risk associated with early-stage MAFLD [2:05:15];
    • Emerging drugs and therapies for addressing fat accumulation and fibrosis related to MAFLD [2:12:15];
    • Peter’s major takeaways [2:18:45]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    The Peter Attia Drive
    enMay 20, 2024

    #301 - AMA #59: Inflammation: its impact on aging and disease risk, and how to identify, prevent, and reduce it

    #301 - AMA #59: Inflammation: its impact on aging and disease risk, and how to identify, prevent, and reduce it

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    In this “Ask Me Anything” (AMA) episode, Peter delves into the often misunderstood concept of inflammation. He first defines inflammation and differentiates between acute inflammation and chronic inflammation, the latter of which is linked to aging and a plethora of age-related diseases. Peter breaks down the intricate relationship between chronic inflammation, obesity, and metabolic health, and highlights the signs that might suggest someone may be suffering from chronic inflammation. From there, the conversation centers on actionable advice and practical steps one can take to manage and minimize chronic inflammation. He explores how diet plays a crucial role, including the potential benefits of elimination diets, and he examines the impact of lifestyle factors such as exercise, sleep, and stress management. Additionally, he discusses the relevance of food inflammatory tests and concludes by examining the potential benefits and drawbacks of drugs and supplements in managing inflammation.

    If you’re not a subscriber and are listening on a podcast player, you’ll only be able to hear a preview of the AMA. If you’re a subscriber, you can now listen to this full episode on your private RSS feed or our website at the AMA #59 show notes page. If you are not a subscriber, you can learn more about the subscriber benefits here.

    We discuss:

    • Defining inflammation (and the cultural impact of Napoleon Dynamite) [1:45];
    • Acute vs chronic inflammation [8:00];
    • The connection between chronic inflammation, aging, and age-related diseases [11:00];
    • The impact of inflammation on metabolic health [18:30];
    • Understanding and diagnosing chronic inflammation: blood tests and other approaches, and challenges with measurement [20:00];
    • Factors that contribute to low-level chronic inflammation [28:00];
    • Minimizing inflammation through diet [29:45];
    • The important role of fiber for gut health and inflammation [33:45];
    • A closer look at the impact of trans fats and saturated fats on overall health [34:45];
    • Why Peter prefers dietary fiber from food sources over supplements [38:30];
    • Debunking “superfoods”: emphasizing proven methods over marketing claims for reducing inflammation [39:00];
    • Is there any value in over-the-counter food inflammatory tests? [42:30];
    • Food elimination diets: how they work, symptoms and markers to watch, challenges and limitations [45:15];
    • Identifying dietary triggers for gut-related symptoms through low-FODMAP diets like the “carnivore diet” [51:15];
    • Dairy: the complex role of dairy on inflammation and individual responses [55:00];
    • Wheat: the complexities and conflicting evidence around wheat's inflammatory effects [57:45];
    • How exercise influences inflammation [1:02:00];
    • How sleep quality and duration impacts inflammation [1:07:00];
    • The potential impact of chronic psychological stressors on inflammation [1:13:00];
    • The impact of oral health on inflammation and overall well-being [1:15:00];
    • The role of medications in managing chronic inflammation [1:18:15];
    • Supplements: evaluating the efficacy of various anti-inflammatory supplements [1:22:15];
    • Parting thoughts and takeaways [1:27:00]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    The Peter Attia Drive
    enMay 13, 2024

    #300 - Special episode: Peter on exercise, fasting, nutrition, stem cells, geroprotective drugs, and more — promising interventions or just noise?

    #300 - Special episode: Peter on exercise, fasting, nutrition, stem cells, geroprotective drugs, and more — promising interventions or just noise?

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    In this special edition celebrating 300 episodes of The Drive, Peter discusses a variety of popular topics and health interventions and classifies them based on their level of evidence and relevance using the following categories: proven, promising, fuzzy, noise, and nonsense. Peter first delves into the topic of geroprotective molecules, covering rapamycin, metformin, NAD and its precursors, and resveratrol. Next, he explores the significance of metrics like VO2 max and muscle mass, as well as emerging concepts like blood flow restriction and stem cells. The conversation extends to nutrition, addressing questions surrounding long-term fasting, sugar consumption, sugar substitutes, and the contentious role of red meat in cancer. Peter not only provides his current stance on each topic—most of which have been covered in great detail in the previous 300 episodes—but also reflects on how his opinion may have evolved over the years.

    We discuss:

    • Defining the categories of “proven, promising, fuzzy, noise, and nonsense” [3:15];
    • Rapamycin [9:30];
    • Metformin [17:00];
    • NAD and its precursors [24:30];
    • Resveratrol [32:45];
    • The importance of VO2 max, muscle mass, and muscular strength for lifespan [38:15];
    • Blood flow restriction (BFR) training [44:00];
    • Using stem cells to treat osteoarthritis or injury [51:30];
    • Fasting as a tool for longevity (and why Peter stopped his fasting protocol) [55:45];
    • The energy balance theory [1:06:30];
    • The idea that sugar is poison [1:12:00];
    • The idea that sugar substitutes are dangerous [1:22:15];
    • The debate on red meat and cancer [1:28:45]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    Special episode with Dax Shepard: F1 and the 30th anniversary of Ayrton Senna’s death

    Special episode with Dax Shepard: F1 and the 30th anniversary of Ayrton Senna’s death

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    This is a special episode of The Drive with Peter’s friend and fellow car enthusiast Dax Shepard. In this podcast, which commemorates the 30th anniversary of the death of Brazilian Formula One legend Ayrton Senna, Dax sits down with Peter to better understand what made Senna so special and why Peter remains an enormous fan. This conversation focuses on Senna’s life, the circumstances of his death, and his lasting impact and legacy on the sport of F1.

    We discuss:

    • Peter’s interest in motorsports began as a child [2:30];
    • The drama and dangers of F1 [6:00];
    • What made Senna special [13:00];
    • What Senna meant to Brazilians [24:00];
    • The cause of the fatal crash [28:15];
    • Why Peter is obsessed with Senna [40:30];
    • Being the best versus having the best record [43:30];
    • Senna’s unique driving style and incredible intuition about automotive engineering [46:30];
    • Back to the day of the dreadful race [53:00];
    • What Peter believes caused the crash [1:02:45];
    • Views on dying young, in the prime of life [1:13:00];
    • Senna lives on in his foundation and in safety changes adopted by F1 [1:21:00];
    • Statistics aren’t enough for fandom, and why people like who they do [1:24:15];
    • The biggest difference between F1 today and F1 in the 80s [1:28:30];
    • Senna’s driving superpower [1:30:30];
    • The fastest drivers currently in F1 [1:38:30];
    • Current F1 obsessions [1:45:00];
    • How hard it is to do what the top F1 drivers do [1:50:15];
    • Dax’s love of motorcycles and his AMG E63 station wagon [1:52:15];
    • Awesome Senna mementos from Etsy [2:01:15];
    • What makes specialists interesting, and Max’s devotion to F1 [2:10:15];
    • What Senna might have done if he had not died that day [2:14:00];
    • Michael Schumacher and Max Verstappen are also top F1 drivers [2:17:30];
    • Interlagos in Sao Paulo Brazil is always an incredible experience [2:18:45]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    #299 ‒ Optimizing muscle protein synthesis: the crucial impact of protein quality and quantity, and the key role of resistance training | Luc van Loon, Ph.D.

    #299 ‒ Optimizing muscle protein synthesis: the crucial impact of protein quality and quantity, and the key role of resistance training | Luc van Loon, Ph.D.

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    Luc van Loon is an internationally renowned expert in skeletal muscle metabolism. In this episode, Luc starts with an exploration of the roles of insulin and triglycerides in endurance exercise, highlighting their impact on skeletal muscle metabolism, and he offers profound insights into the significance of protein in this context. He elucidates how different protein types and forms influence muscle protein synthesis rates, exploring the nuances of protein absorption, digestibility, amino acid quality, and their implications for performance and recovery. Delving deeper, he differentiates between animal and plant protein sources, unraveling the distinctive properties of various protein types, from the differences between whey and casein to the emerging trends in collagen protein supplementation. Moreover, Luc dissects the intricate connections among physical activity, lean muscle mass, muscle protein synthesis induced by resistance training, and dietary protein.

    We discuss:

    • Luc’s background and insights about fuel selection during exercise [3:30];
    • Fuel utilization during endurance exercise [9:30];
    • Fat metabolism, intramuscular lipids, and the nutritional dynamics of endurance sports [17:15];
    • The optimal window for replenishing intramuscular fat stores and glycogen post-exercise [25:15];
    • Luc’s interest in protein metabolism and exploration of amino acids' dual role as building blocks and signaling molecules in driving muscle protein synthesis [32:15];
    • How protein metabolism differs between sedentary individuals and those engaged in predominantly strength training or endurance training [38:45];
    • The basics of how proteins are digested and absorbed, and how muscle protein synthesis is measured [50:30];
    • How factors like food texture, cooking methods, and protein composition impact muscle protein synthesis, and the importance of protein distribution throughout the day [59:45];
    • Differences in whey and casein proteins, and the ability of ingested protein to stimulate muscle protein synthesis [1:03:30];
    • Dietary protein distribution and quantity for the maximization of muscle protein synthesis [1:09:00];
    • Muscle loss with age and inactivity and the importance of resistance exercise to maintain type II muscle fibers [1:17:15];
    • Differences between whey and casein proteins, and the importance of both quantity and quality of protein sources [1:28:30];
    • Optimizing muscle protein synthesis: exercise, timing of protein intake, protein quality, and more [1:37:00];
    • How to preserve muscle while trying to lose weight [1:46:00];
    • Anabolic resistance and overcoming it with physical activity [1:55:45];
    • Importance of protein intake and physical activity in hospitalized patients [2:06:30];
    • Reviewing the efficacy of collagen supplements [2:13:30];
    • Plant-based diets: how to ensure a balance of amino acids, and other considerations [2:20:30];
    • Future research: understanding protein metabolism in the brain [2:23:45]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    Related Episodes

    Is a ton of psychology just ... wrong?

    Is a ton of psychology just ... wrong?
    A decade ago, psychologists realized much of their science was fatally flawed, calling untold numbers of studies into question. Now, some young psychologists are trying to rebuild the foundations of their field. Can they succeed? For more, go to http://vox.com/unexplainable It’s a great place to sign up for our newsletter, view show transcripts, and read more about the topics on our show. Also, email us! unexplainable@vox.com We read every email. Support Unexplainable by making a financial contribution to Vox! bit.ly/givepodcasts Learn more about your ad choices. Visit podcastchoices.com/adchoices

    The W.H.O. and Pandemics with Dr Meryl Nass

    The W.H.O. and Pandemics with Dr Meryl Nass

    Dr. Meryl Nass discusses updates on new pandemics and shots and policies as well as a history of the World Health Organization and older pandemics with Robert F. Kennedy Jr in this episode.


    Dr. Nass mentions Senate and House Bills in the episode; here are the bill numbers and more info:

    House bills: HR 79 to exit and defund the WHO (51 cosponsors) and HR 343 (42 cosponsors)

    Senate bill S444 to require the pandemic treaty to be approved by the Senate •House bill HR1425 does the same •

    The House State Department Foreign Operations appropriations bill draft has $0 funding for the WHO

    --- Send in a voice message: https://podcasters.spotify.com/pod/show/rfkjr/message

    Ep. 1160 - We Are Under Attack

    Ep. 1160 - We Are Under Attack

    A massive suspected Russian cyberhack hits a load of American agencies; Democrats insist on retribution while pushing for wins in Georgia; and stimulus talks continue to drag out.

    Get your copy of "How to Destroy America in Three Easy Steps" here: https://utm.io/uHjV

    If you like The Ben Shapiro Show, become a member TODAY with promo code: SHAPIRO and enjoy the exclusive benefits for 10% off at https://www.dailywire.com/shapiro

    Learn more about your ad choices. Visit podcastchoices.com/adchoices

    Ivermectin: The Story of a Wonder Drug

    Ivermectin: The Story of a Wonder Drug
    Today, we’re digging into the weird and wooly world of ivermectin. When promising papers came out early in the pandemic, a lot of scientists got excited about the drug, but then … cracks started to show. We went down the rabbit hole and realized that there's way more to this story than the headlines. We’ll hear from Dr. Pierre Kory, as well as Jack Lawrence, Dr. Kyle Sheldrick, and Professor Roy Gulick. Find our transcript here: https://bit.ly/3k1dknq Learn more about your ad choices. Visit podcastchoices.com/adchoices